Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?-Reference-Cited by-同舟云学术

Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

Published:2019-05 Issue:5 Volume:72 Page:398-406
ISSN:1885-5857
Container-title:Revista Española de Cardiología (English Edition)
language:en
Short-container-title:Revista Española de Cardiología (English Edition)

Author:

Lekuona Iñaki,Anguita Manuel,Zamorano José Luis,Rodríguez José Manuel,Barja de Soroa Paloma,Pérez-Alcántara Ferran

Publisher

Elsevier BV

Subject

General Medicine

Reference65 articles.

1. Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS;Kirchhof;Rev Esp Cardiol.,2017

2. Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE;Gómez-Doblas;Rev Esp Cardiol.,2014

3. Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012;Camm;Rev Esp Cardiol.,2013

4. Situación del tratamiento anticoagulante oral en pacientes con fibrilación auricular no valvular en España. Estudio REACT-AF;Andrés-Nogales;Rev Clin Esp.,2015

5. The costs of stroke in Spain by aetiology: The CONOCES study protocol;Mar;Neurología.,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review;Applied Health Economics and Health Policy;2023-10-29

2. Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations;Value in Health Regional Issues;2023-01

3. Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma;Frontiers in Oncology;2022-08-29

4. Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain;PLOS ONE;2021-11-12

5. Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis;BMJ Evidence-Based Medicine;2021-10-11